AzTrials
AzTrials

AdenotonsillectomyPhase 4NCT03551067

Oral Dexmedetomidine for Parental Separation in Pediatrics Undergoing Adenotonsillectomy

A Phase 4 study testing Dexmedetomidine and Midazolam/Ketamine in people with Adenotonsillectomy, run by Suez Canal University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The efficacy of oral dexmedetomidine as sedative versus a combination of oral midazolam plus oral ketamine were compared regarding to satisfactory separation from parents, satisfactory mask induction and postoperative rescue analgesia in Pediatrics undergone Adenotosillectomy Read more about this study

Who is it for?
Ages 1 year to 5 years
Conditions the study is for
Adenotonsillectomy
What is being tested?
Dexmedetomidine and Midazolam/Ketamine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
74 participants
Where
1 siteEgypt
Study dates
1 Aug 2016to 5 Jan 2018
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 5 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children with ASA I (American Society of Anesthesiologists physical status Grade I) = (normal healthy patients) or ASA II (American Society of Anesthesiologists physical status Grade II) = (patients with mild systemic disease and no functional limitations)
  • Children scheduled for adenotonsillectomy

Who cannot join

  • Children with central nervous system disorders \& neurological problems.
  • Children with inborn errors of metabolism.
  • Obese children (BMI >30 kg/m2).
  • Children with known allergy to dexmedetomidine, midazolam or ketamine.
  • Children who vomit.
  • Children with recent or chronic administration of sedative drugs, antipsychotics or tranquilizers.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Anesthesia Department, Faculty of Medicine, Suez Canal University

    Ismailia, 41511

Other trials in Egypt

About this study

Official title: The Efficacy OF Oral DexmedetomidineVersus Oral Midazolam/Ketamine ON Parental Separation AND Face Mask Acceptance IN Pediatrics Undergoing Adenotonsillectomy

The efficacy of oral dexmedetomidine as sedative versus a combination of oral midazolam plus oral ketamine were compared regarding to satisfactory separation from parents, satisfactory mask induction and postoperative rescue analgesia in Pediatrics undergone Adenotosillectomy

Read the detailed description

After obtaining approval from the research Ethics Committee of the Suez Canal University Hospitals and written informed consent from the parents of each participant, 74 American Society of Anesthesiologists (ASA) physical status I and ІІ children aged 3-10 years scheduled for adenotonsillectomy under general anesthesia were enrolled into the study.

Patients were randomly assigned into one of two equal groups on alternative basis using closed envelope method; 37 patients for each group.

Group (D): Patients who received oral dexmedetomidine (4 µg/kg) mixed with apple juice to fill the syringe up to 10 ml.

Group (MK): Patients who received a combination of oral midazolam (0.5 mg/kg) and oral ketamine (1 mg/kg) mixed with apple juice to fill the syringe up to 10 ml.

Methods:

I- Preoperative visit:

During the preoperative visit, the following was done:

  1. A written informed consent from the parents of each participant was obtained.
  2. The techniques were explained to the parents including benefits and complications.

II- Preoperative assessment:

This includes:

  1. Medical history:
  2. Medical disorders (as diabetes, heart, chest, liver or kidney diseases).
  3. Past history of operations, hospitalization or blood transfusion.
  4. Past anesthetic history with impact on previous airway problems during previous surgeries, hypersensitivity to anesthetic medications, any previous postoperative complications that could be attributed to anesthesia.
  5. Family history for specific anesthetic problems like malignant hyperthermia.
  6. Physical examination:

1- General examination. 2- Vital signs (heart rate, blood pressure, respiratory rate and temperature). 3- Heart, chest and abdominal examinations.

  1. Anesthetic assessment:
  2. Examination of the limbs for prediction of difficult cannulation.
  3. Airway assessment.
  4. Fasting hours: none of children were given any solid food 6 hours before the operation, but they were allowed to take clear fluids, soft drink or water until 2 hours before induction of anaeshesia.
  5. Laboratory investigations:
  6. Complete blood count (CBC).
  7. Prothrombin time (PT), international normalized ratio (INR) and partial tissue thromboplastin time (PTT).

III- Demograghic data:

The patient's age, sex, weight, height and body mass index (BMI)were recorded.

IV-Intraoperative assessment:

  1. Airway devices, anesthesia machine, ventilator, flowmeters and equipments were checked promptly.
  2. Randomization: participants were randomly allocated to one of two equal groups, (group D) using orally given dexmedetomidine and (group MK) using orally given midazolam/ketamine using block randomization. Concealed allocation: closed envelope method for randomization containing code for dexmedetomidine group (D) or midazolam/ketamine group (MK). To ensure allocation concealment, the envelopes will be prepared by anesthesia nurse not involved in the study. Those enrolled after written informed consent were asked to pick one concealed envelope from the box and hand it over to the investigator concerned. The investigator then assigned to either (D) or (MK) according to the envelope code. Blinding: patients were blinded after assignment to interventions and randomly assigned into one of two equal groups. It was double blinded since the investigator was not aware of both groups.
  3. During the preoperative visit, the researcher explained to the child and family what was done in the morning of surgery. The child was blinded to the used drug and was asked to choose a sealed envelope with his/her code number inside. The name, file number and body weight were recorded on the sealed envelope after been chosen. The on duty anesthetist was blinded to the premedication.
  4. Parents were not aware of the premedication components, but oriented and agreed with our protocol. In the morning of operation, the study medications were prepared by a trained nurse into identical 10 ml syringes that were sequentially numbered. Each labeled syringe was mixed with apple juice to be given to the children. Premedication was given by one of the parents under supervision of anesthetist.
  5. Premedication phase:The attending anesthetist in pre-anesthesia area reported the onset of premedication and level of sedation and the occurrence of vomiting was also monitored; children who vomited were excluded from the study. Thirty minutes after premedication, Parents accompanied their children till the Red-Line of the operating room, but their presence in the induction room was not be permitted according to the policy of the hospital.

Premedication was given orally to the children in the preanaesthetic room. (Group D) patients received dexmedetomidine(4 µg/kg) mixed with apple juice to fill the syringe up to 10 ml given orally and (group MK) patients received a combination of midazolam (0.5 mg/kg) and ketamine (1 mg/kg) mixed with apple juice to fill the syringe up to 10 ml and given orally.

Level of Sedation was assessed by Sedation Score (adapted from Wilton et al)(125)

Sedation and anxiolytics were evaluated in untouched patients. Then additional evaluation of cooperation e.g. (placement of the pulse oximetry sensor, electrocardiogram electrodes and mask induction of anesthesia) was performed.

The sedation score values were condensed to a variable consisting of three categories:

(Levels 1 and 2) Unacceptable conditions. (Levels 3 and 4) Acceptable conditions. (Level 5) Unacceptable deep sedation.

The behavior of the child during preoperative period was evaluated by the anesthesiologist using sedation score; the rating was performed at five different times:

(1) 2.5 minutes after oral drug administration. (2) 5 minutes after oral drug administration. (3)During separation from parents (at levels 3 and 4). (4) During introduction of the anesthesia mask to the child. (5) Immediately postoperative in PACU.

Whatever satisfaction of sedation was achieved or not after 60 min, anesthesia induction was performed.

Onset of sedation was defined as: the minimum time interval necessary for the child to become drowsy or asleep.

Peak sedative effect was defined as: the time interval from drug administration to reach the maximum level of sedation.

Both of onsets of sedation and peak sedative effect were recorded. Sedation and Anxiety levels were recorded every 15 min for a maximum time of 60 min after premedication In case a child came to the operating room already asleep, a steal induction was attempted.

Assessment of drug reaction after drug administration:

1=Crying 2=Not crying 3=Excessive salivation 4=Sneezing 5=cough

Evaluation of drug taste by 4-point scale after oral drug administration:

  1. Good 3= Bitter
  2. Indifferent 4= Unpleasant

6- Induction Phase: Children were transferred to the operating room; inhalational induction via transparent face mask (Jackson-Rees modification of Ayer's T-piece) was done using sevoflurane (Abbott, Abbott Park, Illinois, USA)started at a concentration of 1% and then increased every three breaths to a maximum of 8 % in 100% oxygen (6 L /min).The anesthetist asked the child to blow the balloon.

Five-point scale was used to assess Mask acceptance:

  1. = Combative, crying
  2. = Moderate fear of the mask, not easily calmed
  3. = Cooperative with reassurance
  4. = Calm, cooperative
  5. = Asleep Mask induction scores of 1 and 2 were considered unsatisfactory. Scores of 3-5 were considered a successful response to premedication. After loss of consciousness, an intravenous line was inserted and when adequate depth of anesthesia was reached, endotracheal tube of appropriate size for the age and weight of the child was placed and patient was allowed to breathe spontaneously.

7- Intraoperative Monitoring: Monitoring equipment (Datex-Ohmeda, Helsinki, Finland™) was connected to each patient with standard monitoring including ECG, Non invasive blood pressure, Respiratory Rate, Pulse oximetry, Temperature and both inspiratory and end-expiratory Capnography.

Heart rate and blood pressure were recorded before premedication as a baseline then every 15 min until discharge.

8- Maintenance phase:

  • The anesthetic was delivered in concentration that maintained a stable heart rate, blood pressure and respiratory rate (base line ±20%).
  • Sevoflurane was reduced to 1.5-2 vol% in (30: 70%) oxygen and air ratio.
  • Ventilation was assisted if the end-tidal carbon dioxide increased to ≥ 45 mmHg to be stabilized between 35-40 mmHg.
  • At the end of procedure, anesthetic gas was discontinued and maintained on O2 100% > 5L/min
  • Endotracheal tube was removed when the child showed adequate recovery from anesthesia; child was transferred to PACU for monitoring of vital signs till discharge to the ward.

At the end of anesthesia and before leaving operating room, assessment of recovery according to Modified Aldrete Recovery Score was done.

Adequate recovery was achieved if the score =10

9- Postoperative Period: Child was transferred to the post anesthesia care unit (PACU) for monitoring of vital signs till discharge to the ward.

In the PACU, parents were allowed to remain at the child's bedside immediately upon admission. A trained anesthesiologist, blinded to patient group assignment had been stayed with the patient until discharge to the ward.

Objective Pain Discomfort Score: was assessed, the intensity of pain immediately postoperatively, 30, 60 and 120 min thereafter (Objective Pain Discomfort Scale > 6 means pain and discomfort).

The parameters of this scale were:

Blood Pressure:

2 = > 20% preoperatively

1 = 11-20 % above preoperative 0 = < 11% preoperative

Crying:

2 =Crying not responding to TLC (Tender, Loving, Care)

  1. = Crying but responds to TLC

0 = Not crying

Moving:

2 = Thrashing

1 = Restless 0 = None

Behavior:

2 = Hysterical

1 = Mild 0 = Patient asleep or calm

Verbal evaluation (language):

2 = Moderate pain (localizes verbally or pointing)

1 = Mild pain (cannot localize) 0 = Asleep or no pain

Assessment of agitation:

The state of agitation was assessed at arrival in the recovery room 30, 60 and 120 min postoperatively by means of a modified objective pain discomfort scale.

The modified objective pain Discomfort scale include movement, crying, and behavior items from the full OPS. For these three items, which constituted the modified OPS, the total possible score was 6.

Agitation was defined by a total score of ≥ 3 for these three items.

Patients were discharged when they were awake, had stable vital signs for at least 1 hour, had no pain or only mild pain, had not vomited for 1 hour, were able to tolerate clear fluid by mouth, and had no bleeding.

Duration of anaesthesia, duration of surgery, emergence time (time from the end of surgery till extubation) and recovery time (time from extubation till discharge from recovery): were recorded.

Time to the first request of postoperative analgesia: was recorded. The rescue analgesic was i.v.paracetamol at a dose of 15 mg/kg and if ineffective, fentanyl 0.5µg/kg bolus up to a total dose of 2µg/kg was used.

Complications of level of sedation (such as bradycardia, postoperative pain, shivering, PONV and emergence delirium): were recorded.

Being tested
Dexmedetomidine, Midazolam/Ketamine
Keywords
Dexmedetomidine, Adenotonsillectomy, Parental Separation, Face Mask Acceptance

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • DexmedetomidineDrug

    Also called Alpha 2 agonist

    Dexmedetomidine mixed with juice was given to the child orally preoperatively.

  • Midazolam/KetamineCombination product

    Also called Dormicum/Katalar

    Midazolam/Ketamine was mixed with juice and given to the child orally preoperatively

Study groups in NCT03551067
Study groupRoleWhat they receive
DexmedetomidineActive comparatorPatients received Dexmedetomidine (4 µg/kg) mixed with apple juice to fill the syringe up to 10 ml given orally once.
Receives: Drug: Dexmedetomidine
Midazolam/KetamineActive comparatorPatients received Midazolam (0.5 mg/kg) and Ketamine (1 mg/kg) mixed with apple juice to fill the syringe up to 10 ml given orally once.
Receives: Combination Product: Midazolam/Ketamine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Face mask acceptance

    Five-point scale was used to assess mask acceptance:

    1. = Combative, crying.
    2. = Moderate fear of the mask, not easily calmed.
    3. = Cooperative with reassurance.
    4. = Calm, cooperative.
    5. = Asleep, steal induction. (Scores 1 and 2): Unacceptable conditions. (Scores 3, 4 and 5): Acceptable conditions.

    Measured: The anesthetist asked the child to blow the balloon for induction and assessment was recorded just after anesthesia induction

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jun 2018
  2. Study start1 Aug 2016
  3. Primary completion15 Dec 2017
  4. Study completion5 Jan 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
74 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03551067
Sponsor's protocol ID
2886
Status last verified
Jul 2018
First submitted
8 May 2018
Last updated
5 Jul 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Dexmedetomidine and Midazolam/Ketamine in people with Adenotonsillectomy, run by Suez Canal University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jul 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Face mask acceptance (time frame: The anesthetist asked the child to blow the balloon for induction and assessment was recorded just after anesthesia induction). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jul 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in